Podcasts
Human Resources

The 2027 Benefits Cost Shock: Reading the 8% to 11% Projections

Fizza Fatima NaqviAugust 27, 20267 min read
The 2027 Benefits Cost Shock: Reading the 8% to 11% Projections

Key takeaways

  • Variable projections: Analysts project 2027 healthcare cost increases between 8.2% and 11.1% depending on whether employers implement mitigation efforts (fiercehealthcare.com) (thefiscaltimes.com).
  • Mitigation impact: Plan design changes may reduce projected cost growth from double digits to approximately 8% or 9.7% (planadviser.com) (thefiscaltimes.com).
  • Primary drivers: Rising GLP-1 utilization and hospital price increases are identified as significant contributors to rising premiums (fiercehealthcare.com) (medcitynews.com).
  • Employer response: Approximately 59% of employers intend to make cost-cutting changes to health benefits in the coming year (fiercehealthcare.com).

Marsh analysts project that employers' healthcare costs could rise 8.2% in 2027 (fiercehealthcare.com). This figure reflects a complex intersection of clinical trends, regulatory shifts, and employer-led mitigation efforts. As we approach the 2027 plan year, the data suggests a widening gap between what costs might be if left unchecked and what they might become if organizations take proactive steps to manage spending (fiercehealthcare.com).

The gap between baseline and mitigated costs

A central tension in current healthcare forecasting is the difference between "unmitigated" costs and "mitigated" costs. When analysts look at the trajectory of spending, they often provide two distinct numbers: one representing the cost if current plan designs remain static, and another representing the cost after employers implement changes (fiercehealthcare.com) (planadviser.com).

For example, WTW anticipates an 11.1% increase in healthcare costs in 2027 if no changes are made, but expects that number to drop to 9.7% if plan design changes are implemented (planadviser.com). Similarly, employers in one survey predicted a median increase of 9.2%, which could potentially drop to 8% following plan modifications (medcitynews.com).

This distinction is critical for HR leaders. It suggests that the "shock" of 2027 is not a fixed number, but a variable that is partially within the control of the employer. However, this control comes with a trade-off. The mechanism that reduces the cost increase is almost always a change in the plan design, which shifts some of the financial responsibility or the decision-making burden onto the employee (fiercehealthcare.com).

Analysis of these projections shows that while the "shock" is significant, the actual impact on a company's bottom line is highly dependent on the speed and nature of these interventions. If an organization waits until the last minute to decide on plan design, they may find themselves stuck with the higher, unmitigated rate (planadviser.com).

Few organizations can absorb health cost increases that outpace inflation without making difficult financial decisions (fiercehealthcare.com).

Why It Matters

What is driving the upward pressure?

To understand why these numbers are rising, we must look at the specific drivers identified by researchers and employers. The data points to three primary mechanisms: pharmaceutical utilization, hospital pricing, and regulatory processes.

First, pharmacy spending is a massive component of the total cost, representing 25% of total healthcare spending (medcitynews.com). Within this category, a specific trend is emerging. Marsh analysts estimate that rising GLP-1 utilization accounts for a full percentage point of the overall cost growth for 2027 (fiercehealthcare.com). Currently, 68% of employers are seeing an increase in the utilization of GLP-1s for weight management (medcitynews.com). This shift in demand for high-cost specialty drugs creates a predictable but significant upward pressure on pharmacy budgets (medcitynews.com).

Second, hospital pricing remains a heavy driver. About 62% of employers report that hospital price increases are driving costs to a great or very great extent (medcitynews.com). This is a structural cost that employers have very little direct control over, as it is determined by the negotiations between insurers and hospital systems (medcitynews.com).

Third, the regulatory environment plays a role. The No Surprises Act’s Independent Dispute Resolution (IDR) process has been cited as a driver of costs (fiercehealthcare.com). This mechanism, designed to protect patients from unexpected out-of-network bills, has introduced new complexities into the cost structure of healthcare services (fiercehealthcare.com).

What the data does not say is exactly how much of the 2027 increase is due to medical inflation versus the sheer volume of services used. We see the correlation between higher utilization and higher costs, but the data does not isolate whether the cost per service is rising faster than the frequency of service use (fiercehealthcare.com) (medcitynews.com).

Comparing the projections: A summary of analyst views

Because different organizations use different methodologies, the projected percentages vary. Some surveys rely on self-reported data from employers, while others use modeling based on historical trends and current market data (planadviser.com).

Source / Survey Type Projected Increase (Unmitigated) Projected Increase (Mitigated)
WTW Survey (471 employers) 11.1% 9.7%
Aon (Projected Spike) 9.5% N/A

Note: Figures are based on the most recent available survey data as of August 2026 (fiercehealthcare.com) (planadviser.com) (thefiscaltimes.com) (medcitynews.com).

Analysis of this table shows that while the exact percentage is debatable, the direction is unanimous. Every major projection suggests that the "unmitigated" cost is significantly higher than the "mitigated" cost. This confirms that the primary lever for controlling the 2027 budget is the decision to change plan design (fiercehealthcare.com) (planadviser.com) (thefiscaltimes.com).

The employee experience: The cost of mitigation

When we discuss "plan design changes," we are often discussing how to move from the higher percentage to the lower percentage. For an HR professional, this is a delicate balancing act. The mechanism used to lower the employer's cost increase often involves shifting costs to the employee or limiting access to certain high-cost services.

We see evidence of this in the way employers are handling specific high-cost trends. For instance, 14% of employers have dropped or will drop GLP-1 coverage in 2027 (medcitynews.com). This is a direct response to the utilization trends mentioned earlier. For the organization, this is a mitigation strategy. For the employee, this may feel like a reduction in benefits or a loss of access to care.

Also, 26% of employers plan to offer an alternative health plan in 2027 (medcitynews.com). This could mean offering a high-deductible health plan (HDHP) alongside a traditional PPO, or perhaps a different network structure entirely. The goal is to give employees choices, but the underlying driver is the need to manage the 76% cumulative cost increase seen over the last decade (planadviser.com).

Most employers have already locked in their budgets and strategies for the next year (planadviser.com).

Watch For

The strategic tension: Inflation vs. Benefits

There is a fundamental economic tension at play for the executive team. As Simon Camaj of Marsh noted, few organizations can absorb health cost increases that outpace inflation without making difficult financial decisions (fiercehealthcare.com).

If an employer chooses not to change plan design, they are essentially choosing to absorb a cost increase that is likely higher than the general rate of inflation. This can impact the company's ability to fund other areas, such as salary increases, training, or capital investments. Conversely, if the employer does change the plan design to keep the increase closer to 8%, they risk impacting employee satisfaction and the perceived value of the total rewards package (fiercehealthcare.com) (planadviser.com).

This is why the timing of these decisions is so critical. As Ellen Kelsay noted in August 2026, most employers have already locked in their budgets and strategies for the next year (planadviser.com). This means the window for significant, structural changes to the 2027 benefits strategy is closing rapidly. The decisions being made now will dictate the financial and cultural impact of healthcare for the next twelve months.

What HR can do on Monday morning

While the macro trends are driven by hospital pricing and pharmaceutical shifts, the micro decisions belong to the HR team. To prepare for the 2027 cycle, we should move away from vague discussions about "managing costs" and toward specific, data-driven actions.

Here is a checklist for HR teams to run this week:

  1. Audit GLP-1 utilization: Request a report from your current carrier specifically for GLP-1 spend and utilization rates. Compare this to your total pharmacy spend to see if your organization is trending toward the 68% of employers seeing significant increases (medcitynews.com).
  2. Run a "No-Change" Scenario: Ask your benefits broker to model your 2027 premiums based on the current plan design with no modifications. This is your "unmitigated" baseline (fiercehealthcare.com).
  3. Analyze the "Mitigation Gap": Calculate the difference between your "No-Change" baseline and the projected cost if you implement one major change (such as a higher deductible or a change in the pharmacy formulary). This is the "cost of inaction" (planadviser.com).
  4. Review Alternative Plan Options: If you do not currently offer a high-deductible health plan (HDHP) or a second plan option, request a feasibility study for offering one in 2027 (medcitynews.com).

The 2027 benefits landscape will be defined by the tension between rising medical costs and the necessity of fiscal responsibility. By understanding the specific mechanisms, from GLP-1 trends to the No Surprises Act, HR leaders can move from being reactive to being strategic architects of the company's total rewards package.

Written byFizza Fatima Naqvi

Fizza helps organizations strengthen the people side of performance, from recruitment and onboarding to performance management, training, and employee relations. An HR professional with an MBA in Human Resource Management and a BBA with Honours, she has hands-on experience as an HR Generalist, supporting recruitment, onboarding, performance appraisal, HR policy implementation, and employee training workshops. Her grounding in research methodology and statistical analysis informs how she approaches human resource questions.